MedPath

Cross-sectional study of the effectiveness and safety of proton beam therapy for liver metastatic 3 or less lesions in gastric cancer patients without extrahepatic lesio

Not Applicable
Conditions
Gastric cancer
Registration Number
JPRN-UMIN000041791
Lead Sponsor
Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University
Brief Summary

1. The 3-year control rates were 85.7%. 2. The 3-year overall survival rates were 68.6%. 3. The 3-year progression-free survival rates were 43%. 4. No grade >= 3 adverse events were observed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
7
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients without follow-up data

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Local control rates 2. Overall survival rates 3. Progression-free survival rates 4. Adverse events
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath